ArticleCancer management and research2011

Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies.

Ken Tawara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.